Panel Discussion: What is the Current State of Play for IVDR & Regulation Across Europe?
Time: 9:30 am
day: Conference Day One - AM
Details:
- Over the last year of IVDR, what challenges still persist?
- How are non-European-based companies working through IVDR? How is this different to Europe?
- What are the main hurdles are faced in clinical development phase for CDx?
- What are the main hurdles faced for CE-Marked certification?
- Where are we with the combine trial and what more needs to be done to advance the field forward?
